Received Feb 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 025B21A | IM / LA |
Hospitalization related to COVID 19 following completion of primary vaccine series
Actinic keratoses (L57.0) o Allergic rhinitis (J30.9) o Eustachian tube dysfunction, right (H69.81) o Gross hematuria (R31.0) o Health care maintenance (Z00.00) o Hearing loss (H91.90) o Hyperlipidemia, unspecified (E78.5) o Hypertension (I10) o Iron deficiency anemia (D50.9) o Leukopenia (D72.819) o Normocytic anemia (D64.9) o Presbyopia of both eyes (H52.4) o Skin lesion of face (L98.9) o Special screening for other malignant neoplasms (Z12.9) o Stage III chronic kidney disease (N18.30)
Actinic keratoses (L57.0) o Allergic rhinitis (J30.9) o Eustachian tube dysfunction, right (H69.81) o Gross hematuria (R31.0) o Health care maintenance (Z00.00) o Hearing loss (H91.90) o Hyperlipidemia, unspecified (E78.5) o Hypertension (I10) o Iron deficiency anemia (D50.9) o Leukopenia (D72.819) o Normocytic anemia (D64.9) o Presbyopia of both eyes (H52.4) o Skin lesion of face (L98.9) o Special screening for other malignant neoplasms (Z12.9) o Stage III chronic kidney disease (N18.30)
amLODIPine Besylate 5 MG Oral TabletTAKE 1 TABLET DAILY.Atorvastatin Calcium 10 MG Oral TabletTAKE 1 TABLET BY MOUTH AT BEDTIMEFlonase Allergy Relief 50 MCG/ACT Nasal Suspension (Fluticasone Propionate)USE 1 SPRAY IN EACH NOSTRIL ONCE DAILY
No Known Allergies
Covid positive test date 01/21/2026